FDA Investigator Linda M Cheny

Linda M Cheny has inspections in 6 countries as of 20 Oct 2023. Linda M Cheny has collaborated with a combinined 5486 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
411
Last Inspection Date:
20 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America, Switzerland, United Kingdom of Great Britain and Northern Ireland, Poland, Canada
Co-Investigator(s):
Ademola O Daramola, Alan P Kurtzberg, Alanna Lmussawwir Bias, Alicia A Armijo, Alvaro G Dominguez, Amanda S Zorn, Amy A Johnson, Amy Johnson, Ana C Lazo, Andrea J Schmidt, Andrea S Heise, Andrew C Durfor, Andrew Le, Andrew M Kolenc, Anita Narula, PhD, Anjali Shukla, PhD, Anthony J Lagreca, Arindam Dasgupta, PhD, Ashleigh P Barkans, Ashleigh P Wodushek, Ashley M Caputo, Barbara J White, Becky Bhan, Becky L Bhan, Benjamin P Stewart, Betty K Baxter, Betty Kay Baxter, Brandon K Lawson, Brent W Higgs, Brian S Erickson, Brittany R Laymon, Bruce E Taylor, Bruce H Mccullough, Bryan J Love, Bryce A Hammer, Carl J Montgomery, Carla R Hinz, Carmen Ramirez, Carolina D Vasquez, Caroline H Le, Carolyn J Cook, Carrie E Jolly, Carterm, Chani Broner, PhD, Charles I Ann, Christin L Torres, Christina D Mello, Christine I Shaw, Christine L Williams, Christine R Casey, Christopher J Freebairn, Christopher M Sheehan, Comyar Shoghi, Courtney R Bratina, Courtney R Ingalsbe, Crystal Monroy, Cynthia J Lee, MS, Cynthia Jim, CSO, Cynthia M Goudeau, Daniel J Lahar, Daniel Pst Laurent, David A Gonzalez, David M Beltran, Deborah S Hammond, Debra Curtis, Debra D Devlieger, Debra L Boyd Seale, Debra L Curtis, Denicia L Hernandez, Diane Cvan Leeuwen, Dianna D Wardlow Dotter, Dogbeda F Mackenzie, Don H Bark, PhD, Donald R Hawn, Doris E Farmer, Doris M Sachanandani, Ebony W Laster, Edith M Gonzalez, Edmund F Mrak, Jr, Elaine G Stewart, Elisa J Beard, Elvin R Smith, Eric R Holm, Eric S Myskowski, Erik W Burrows, Erika V Butler, Erin P Conlin, Erma Zaimova, Esther C Broner, PhD, Farhana Khan, Felicia M Orlando, Felix J Marrero, Francisco J Mendoza, Frank L Cordova, Frederick L Fricke, Frederick Razzaghi, Garrad R Poole, Gary C Pecic, Gerard T Schneider, Gina M Scholze, Ginger M Sykes, Gloria A Milster, Grace E Mcnally, Gwyn G Dickinson, Hanna L Potter, Haroon Vohra (NMI), Helen B Ricalde, Holly L Miller, Hong Song, Ian M Carrico, Isabel Y Espinosa, Isaiah D Isakson, Isatu N Bah, Ismael Olvera, IV, James D Bradley, James D Romero, James R Montero, Jamie L Dion, Jamie L Port, Janet Pulver, Janete A Oliveira, Jeffrey D Meng, Jennifer A Baker, Jennifer A Kinney, Jennifer A Robinson, Jennifer L Wolfe, Jennifer R Mathern, Jessica M Christman, Jessica M Ector, Jessie E Morris, Jin M Kim, Joel D Hustedt, John A Gonzalez, Jonathan E Campos, Jonathan R Campos, Juan A Morales, Judy M Amaya, Justin H Erickson, Justin R Carr, Kalavati Suvarna, PhD, Kamara Co, Karen A Wolnik, Karen G Hirshfield, Karen M Cooper, Katherine Szestypalow, Kathleen A Watts, Kathleen S Tormey, Kathryn M Megen, Kathryn M Mogen, Keith C Littrell, Kelly D Moore, Kenneth V Miller, Kent C Faul, Kevin D Kallander, Kham Phommachanh, Khumo A Phake, Kim Lthomas Cruse, Kimberley A Hoefen, Kimberley Buylaert Hoefen, Kimberly A Peterson, Kristen E Szenderski, Larisa E Pavlick, Larry Gehring, Laura B Kennedy, Laura L Staples, Laura L Van Wagenen, Lavender M Huskey, LCDR Debra Emerson, Lequita M Mayhew, Liliane Brown, Linada Cherry, Linda F Murphy, Lisa Shin, Lori A Carr, Luis A Salinas, Manuel A Moreno, Marc A Jackson, Jr, Margaret M Annes, Marie Bbuen Bigornia, Marion Michaelis, Marion W Nadeau, Mariza M Jafary, Marlene G Swider, Marsha L Mccauley, Martina E Lagrange, Mary F Bodick, Matthew A Johnson, Matthew A Kozler, Matthew J Gretkierewicz, Matthew J Hansen, Matthew M Vernon, Matthew R Clabeaux, Matthew R Dionne, Mei Chiung J Huang, Melissa F Chauvin, Melissa J Nucci, Melkamu Getie Kebtie, PhD, Michael A Charles, Michael E Maselli, Michael J Kuchta, Michael Kuchta, Michael L Zimmerman, Michael R Goga, Michael S Araneta, Michele L Forster, PhD, Michele L Obert, Mihaly S Ligmond, Mikayla K Deardorff, Milinda F Soukup, Min Lu, Mohammad Heidaran, PhD, Mohsen Rajabi Abhari, FDA, Mpris Inspector, Nalini D Lebzelter, Nancy G Schmidt, Narahi J Alvarez Alcazar, Nathan M Jornod, Nathan R Moon, Nayan J Patel, Neira Acevedo Ramos, Nicholas M Smith, Nicola M Fenty Stewart, Olious D Evans, Omotunde O Osunsanmi, Parul M Patel, Patricia A Brown, Patricia A Cortez, Patricia A Maestas, Patricia Brown, Patricia D Stahnke, Paul J Teitell, Paul L Dexter, Paul M Chefor, Paul Z Balcer, Philip E Ake, Prabhu P Raju, Rafeeq A Habeeb, Ramesh Raghavachari, Randy L Self, Randy V Bong, Rebecca H Lee, Rebecca Rodriguez, Rebecca S Secrist, Regina T Brown, Richard T Jensen, Ricki A Chase, Robert C Coleman, Robert Sharpnack, Roger F Zabinski, Roger L Farmer, Ruth A Williams, Samantha E Rafferty, Santiago Gallardo Johnson, Secrist, Seneca D Toms, Shawn R Gould, Sheila Alaghemand, Shelley H Beausoleil, Shererk, Sidney B Priesmeyer, Siobhan A Gallagher, Siobhan G Taylor, Solomon G Williams, Sri H Pfuntner, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stanley Au, State Agency, Stefanie R Cook, Stephen T Hansen, Steve P Yost, Steve Y Rhieu, PhD, Steven C Madzo, Steven O Gauthier, Susan M Jackson, Tamara L Setzer, Tamayo C Barnes, Tania E Vogel, Tara L Breckenridge, Tara L Greene, Teena H Aiken, Tenzin Jangchup, Teresa I Navas, Terri L Thomas, Thaddeus M Steinke, Thai T Duong, Theressa B Smith, Thomas A Peter, Thomas J Arista, Thomas J Moore, Thomas V Anderson, Toni L Morales, Tracy K Li, Travis S Bradley, Trevor R Beach, Trinidad D Barreras, Tuan A Nguyen, Vashti E Bocker, Vicky L Cruz, Virginia L Sheldon, Vlada Matusovsky, Wayne E Seifert, Wdouglas Rowe, Wendy C Andersen, William A Lanier, Xiaokuang Lai, PhD, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm, Zachary P Wachlarowicz, Zhong Li, PhD

Linda M Cheny's Documents

Publish Date Document Type Title
November, 2006 FDA 483 OraLabs, Inc - Form 483, 2006-11-28
December, 2004 FDA 483 Alan Levine, MD - Form 483, 2004-12-08
October, 2010 FDA 483 UnitDrugCo., LLC - Form 483, 2010-10-28
March, 2017 FDA 483 Cutler, Jeffrey L. MD - Form 483, 2017-03-13
February, 2010 FDA 483 B&B Pharmaceuticals, Inc. - Form 483, 2010-02-08
November, 2008 FDA 483 CryoGam Colorado, LLC. - Form 483, 2008-12-02
August, 2011 FDA 483 Response John D. Papilion, M.D. - Form 483R, 2011-09-09
September, 2002 EIR Computerized Thermal Imaging - EIR, 2002-09-24
February, 2015 FDA 483 Lewis, Karl D. MD - Form 483, 2015-02-20
September, 2002 FDA 483 Computerized Thermal Imaging - Form 483, 2002-09-24
May, 2006 FDA 483 Alera Technologies, Inc. - Form 483, 2006-05-05
August, 2013 EIR Aliri USA Inc. - EIR, 2013-08-30
August, 2006 FDA 483 Aqueous Biomedical, Inc. - Form 483, 2006-08-10
June, 2018 FDA 483 Esoterix Clinical Trials Services - Form 483, 2018-06-27
June, 2015 FDA 483 AlloSource - Form 483, 2015-06-11
July, 2018 FDA 483 Lindley, Emily M. - Form 483, 2018-07-17
October, 2003 EIR Sandoz Incorporated - EIR, 2003-10-29
February, 2009 FDA 483 Aliri USA Inc. - Form 483, 2009-02-12
July, 2005 EIR Okami, Incorporated - EIR, 2005-07-28
March, 2011 FDA 483 Neoteric Cosmetics, Incorporated - Form 483, 2011-03-07
February, 2017 FDA 483 Dunnick, Cory A. MD - Form 483, 2017-02-27
February, 2009 EIR Aliri USA Inc. - EIR, 2009-02-12
June, 2015 EIR AlloSource - EIR, 2015-06-11
August, 2011 EIR John D. Papilion, M.D. - EIR, 2011-08-11
February, 2015 EIR Lewis, Karl D. MD - EIR, 2015-02-20
June, 2018 EIR Esoterix Clinical Trials Services - EIR, 2018-06-27
June, 2018 FDA 483 Response Esoterix Clinical Trials Services - Form 483R, 2018-07-11
February, 2017 EIR Dunnick, Cory A. MD - EIR, 2017-02-27
November, 2011 EIR VRL Eurofins - EIR, 2011-11-03
June, 2018 EIR Sara Hurvitz, MD - EIR, 2018-06-08
March, 2003 EIR Redbeast Enterprises Inc dba High Quality Research - EIR, 2003-03-13
June, 2015 FDA 483 Cerapedics, Inc. - Form 483, 2015-06-05
March, 2012 EIR VRL Eurofins - EIR, 2012-03-15
March, 2009 FDA 483 Simec AG - Form 483, 2009-03-30
April, 2015 EIR Melamed, Isaac R. , M.D. - EIR, 2015-04-01
June, 2015 FDA 483 Response AlloSource - Form 483R, 2015-06-30
July, 2003 EIR Sandoz Incorporated - EIR, 2003-07-23
September, 2006 FDA 483 Sandoz Incorporated - Form 483, 2006-09-27
March, 2012 FDA 483 VRL Eurofins - Form 483, 2012-03-19
August, 2005 EIR Richard C. Dart, MD, PhD - EIR, 2005-08-22
August, 2013 FDA 483 Aliri USA Inc. - Form 483, 2013-08-30
August, 2011 FDA 483 John D. Papilion, M.D. - Form 483, 2011-08-11

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more